Ind-Swift Laboratories Limited has informed the Exchange regarding allotment of 8124698 securities pursuant to Scheme of Arrangement/Amalgamation at its meeting held on August 25, 2025
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ind-Swift Laboratories has allotted 81,24,698 fully-paid equity shares of Rs 10 each to eligible shareholders of Ind-Swift Limited (the transferor company) as part of the Scheme of Amalgamation. The record date for determining eligible shareholders was August 14, 2025. An additional 5,559 shares were allotted to a trustee to handle fractional entitlements, with net sale proceeds to be distributed within 90 days. The company will apply for listing of these new shares on BSE and NSE, and they will remain frozen until trading permission is granted. This follows the earlier filing of E-Form INC-28 with the Registrar of Companies on August 8, 2025, confirming the scheme has received regulatory clearance.
This is a share issuance that will dilute existing shareholders by approximately the proportion of new shares being issued. Once listed, the expanded share capital will begin trading, increasing liquidity but spreading ownership across the combined entity's shareholder base.